688513 苑东生物
已收盘 10-30 15:00:00
资讯
新帖
简况
苑东生物(688513)10月27日主力资金净卖出1053.44万元
证券之星 · 10-28
苑东生物(688513)10月27日主力资金净卖出1053.44万元
图解苑东生物三季报:第三季度单季净利润同比下降5.65%
证券之星 · 10-28
图解苑东生物三季报:第三季度单季净利润同比下降5.65%
10月27日苑东生物跌10.64%,博时主题LOF基金重仓该股
证券之星 · 10-27
10月27日苑东生物跌10.64%,博时主题LOF基金重仓该股
苑东生物跌10.64% 中泰证券今刚喊给予买入评级就跌
中金财经 · 10-27
苑东生物跌10.64% 中泰证券今刚喊给予买入评级就跌
股市必读:苑东生物新发布《苑东生物:关于召开2026年第三季度业绩说明会的公告》
证券之星 · 10-22
股市必读:苑东生物新发布《苑东生物:关于召开2026年第三季度业绩说明会的公告》
苑东生物(688513)披露召开2026年第三季度业绩说明会公告,10月20日股价上涨4.66%
证券之星 · 10-20
苑东生物(688513)披露召开2026年第三季度业绩说明会公告,10月20日股价上涨4.66%
股市必读:苑东生物新发布《苑东生物:关于自愿披露泊那替尼片获得药品注册证书的公告》
证券之星 · 10-19
股市必读:苑东生物新发布《苑东生物:关于自愿披露泊那替尼片获得药品注册证书的公告》
股市必读:苑东生物新发布《苑东生物:关于自愿披露维生素K?注射液获得药品注册证书的公告》
证券之星 · 10-12
股市必读:苑东生物新发布《苑东生物:关于自愿披露维生素K?注射液获得药品注册证书的公告》
苑东生物最新公告:维生素K₁注射液获药品注册证书
证券之星 · 10-08
苑东生物最新公告:维生素K₁注射液获药品注册证书
10月8日苑东生物跌7.15%,博时主题LOF基金重仓该股
证券之星 · 10-08
10月8日苑东生物跌7.15%,博时主题LOF基金重仓该股
股市必读:苑东生物新发布《北京植德律师事务所关于成都苑东生物制药股份有限公司2026年第三次临时股东会的法律意见书》
证券之星 · 09-30
股市必读:苑东生物新发布《北京植德律师事务所关于成都苑东生物制药股份有限公司2026年第三次临时股东会的法律意见书》
苑东生物(688513)披露2026年第三次临时股东会决议公告,9月28日股价下跌1.0%
证券之星 · 09-28
苑东生物(688513)披露2026年第三次临时股东会决议公告,9月28日股价下跌1.0%
每周股票复盘:机构调研关注苑东生物(688513)研发进展
证券之星 · 09-20
每周股票复盘:机构调研关注苑东生物(688513)研发进展
苑东生物最新公告:EP-0226片完成I期临床试验
证券之星 · 09-16
苑东生物最新公告:EP-0226片完成I期临床试验
9月14日苑东生物涨6.49%,博时主题LOF基金重仓该股
证券之星 · 09-14
9月14日苑东生物涨6.49%,博时主题LOF基金重仓该股
苑东生物(688513)披露召开2026年第三次临时股东会的通知,9月11日股价下跌4.04%
证券之星 · 09-11
苑东生物(688513)披露召开2026年第三次临时股东会的通知,9月11日股价下跌4.04%
苑东生物:公司将于9月16日参加科创板2026年半年度创新药行业集体业绩说明会
证券日报 · 09-08
苑东生物:公司将于9月16日参加科创板2026年半年度创新药行业集体业绩说明会
苑东生物(688513)披露2026年第二次临时股东会决议公告,9月8日股价下跌1.63%
证券之星 · 09-08
苑东生物(688513)披露2026年第二次临时股东会决议公告,9月8日股价下跌1.63%
22家公司披露回购进展,ST绝味、苑东生物、佛燃能源回购金额居前
同花顺 · 09-08
22家公司披露回购进展,ST绝味、苑东生物、佛燃能源回购金额居前
股市必读:苑东生物新发布《苑东生物:关于股份回购实施结果的公告》
证券之星 · 09-07
股市必读:苑东生物新发布《苑东生物:关于股份回购实施结果的公告》
暂无数据
公司概况
公司名称:
成都苑东生物制药股份有限公司
所属行业:
医药制造业
上市日期:
2020-09-02
主营业务:
成都苑东生物制药股份有限公司的主营业务是化学原料药、高端化学药及生物药研发、生产和销售。公司的主要产品是化学制剂、化学原料药、CMO/CDMO、技术服务及转让。公司是国家高新技术企业,拥有“国家企业技术中心”、“博士后科研工作站”、“四川省固态药物工程技术研究中心”等多个创新平台,先后被认定为国家技术创新示范企业、国家企业技术中心、国家知识产权示范企业、国家绿色工厂,多次荣登中国化药企业百强、中国医药创新企业百强等榜单。
发行价格:
44.36
{"stockData":{"symbol":"688513","market":"SH","secType":"STK","nameCN":"苑东生物","latestPrice":41.05,"timestamp":1793343600000,"preClose":41.77,"halted":0,"volume":1096497,"delay":0,"changeRate":-0.0172,"floatShares":177000000,"shares":177000000,"eps":1.5438,"marketStatus":"已收盘","change":-0.72,"latestTime":"10-30 15:00:00","open":41.12,"high":43.09,"low":40.88,"amount":45758300,"amplitude":0.0529,"askPrice":41.05,"askSize":0,"bidPrice":41.03,"bidSize":1,"shortable":0,"etf":0,"ttmEps":1.5438,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793583000000},"marketStatusCode":5,"adr":0,"adjPreClose":41.77,"symbolType":"stock_kcb","openAndCloseTimeList":[[1793323800000,1793331000000],[1793336400000,1793343600000]],"highLimit":45.95,"lowLimit":37.59,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":176532256,"isCdr":false,"pbRate":2.42,"roa":"--","peRate":26.590232,"roe":"6.97%","epsLYR":1.63,"committee":-0.346939,"marketValue":7247000000,"turnoverRate":0.0062,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-11-02。","afterMarket":{"amount":0,"volume":0,"close":41.05,"buyVolume":0,"sellVolume":0,"time":1793345637746,"indexStatus":"已收盘 10-30 15:30:00","preClose":41.77},"floatMarketCap":7247000000},"requestUrl":"/m/hq/s/688513/tweets","defaultTab":"tweets","newsList":[{"id":"2678480981","title":"苑东生物(688513)10月27日主力资金净卖出1053.44万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678480981","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678480981?lang=zh_cn&edition=full","pubTime":"2026-10-28 08:38","pubTimestamp":1793147915,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月27日收盘,苑东生物报收于40.8元,下跌10.64%,换手率2.5%,成交量4.42万手,成交额1.88亿元。近5日资金流向一览见下表:苑东生物融资融券信息显示,融资方面,当日融资买入1289.43万元,融资偿还1013.63万元,融资净买入275.8万元。苑东生物主营业务:以研发创新驱动,集化学原料药、高端化学药品及生物药品研发、生产、销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800014048.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688513","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678410400","title":"图解苑东生物三季报:第三季度单季净利润同比下降5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678410400","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678410400?lang=zh_cn&edition=full","pubTime":"2026-10-28 01:12","pubTimestamp":1793121172,"startTime":"0","endTime":"0","summary":"证券之星消息,苑东生物2026年三季报显示,前三季度公司主营收入9.9亿元,同比下降2.81%;归母净利润2.09亿元,同比下降5.24%;扣非净利润1.65亿元,同比下降4.56%;其中2026年第三季度,公司单季度主营收入3.32亿元,同比下降9.09%;单季度归母净利润7886.62万元,同比下降5.65%;单季度扣非净利润7140.87万元,同比上升3.21%;负债率22.2%,投资收益461.03万元,财务费用28.81万元,毛利率76.52%。财报数据概要请见下图:本文数据来源于苑东生物2026年三季报,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800002580.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678124190","title":"10月27日苑东生物跌10.64%,博时主题LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678124190","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678124190?lang=zh_cn&edition=full","pubTime":"2026-10-27 16:54","pubTimestamp":1793091268,"startTime":"0","endTime":"0","summary":"证券之星消息,10月27日苑东生物跌10.64%创60日新低,收盘报40.8元,换手率2.5%,成交量4.42万手,成交额1.88亿元。根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共11家,其中持有数量最多的公募基金为博时基金的博时主题LOF。石炯在任的基金产品包括:博时研究优选混合A,管理时间为2023年9月1日至今,期间收益率为-9.91%;博时主题LOF的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700031573.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["160505","BK0239","688513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678290031","title":"苑东生物跌10.64% 中泰证券今刚喊给予买入评级就跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2678290031","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678290031?lang=zh_cn&edition=full","pubTime":"2026-10-27 16:22","pubTimestamp":1793089321,"startTime":"0","endTime":"0","summary":"中国经济网北京10月27日讯 苑东生物(688513.SH)今日收报40.80元,跌幅10.64%。\n\n 中泰证券股份有限公司研究员祝嘉琦今日发布研报《苑东生物(688513):仿创结合快速成长 TPD平台价值持续发现》。研报指出,预计2026-2028年收入13.81、16.26、19.40亿元,同比增长3.74%、17.70%、19.32%;归母净利润2.62、2.66、2.69亿元,同比增长-7.83%、+1.77%、+1.05%,对应PE分别为31.2、30.7、30.3倍,给予“买入”评级。\n\n \n\n \n\n (责任编辑:华青剑)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20261027/32408945.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688513","600918"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677093126","title":"股市必读:苑东生物新发布《苑东生物:关于召开2026年第三季度业绩说明会的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677093126","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677093126?lang=zh_cn&edition=full","pubTime":"2026-10-22 02:10","pubTimestamp":1792606223,"startTime":"0","endTime":"0","summary":"截至2026年10月21日收盘,苑东生物报收于46.95元,下跌1.92%,换手率0.72%,成交量1.27万手,成交额6021.65万元。公司公告汇总:苑东生物将于10月29日召开2026年第三季度业绩说明会,10月28日披露2026年第三季度报告。投资者可于2026年10月22日至10月28日16:00前通过上证路演中心网站或公司邮箱ydsw@eastonpharma.cn提问。说明会结束后可通过上证路演中心查看会议内容。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200001477.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688513","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676941706","title":"苑东生物(688513)披露召开2026年第三季度业绩说明会公告,10月20日股价上涨4.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676941706","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676941706?lang=zh_cn&edition=full","pubTime":"2026-10-20 22:34","pubTimestamp":1792506853,"startTime":"0","endTime":"0","summary":"截至2026年10月20日收盘,苑东生物报收于47.87元,较前一交易日上涨4.66%,最新总市值为84.51亿元。该股当日开盘45.08元,最高47.88元,最低44.68元,成交额达6037.03万元,换手率为0.73%。公告显示,公司将于2026年10月29日11:00-12:00通过上证路演中心网络互动方式召开2026年第三季度业绩说明会,介绍公司经营成果和财务状况。投资者可于2026年10月22日至10月28日16:00前通过上证路演中心网站或公司邮箱ydsw@eastonpharma.cn提问。说明会结束后可通过上证路演中心查看会议内容。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000037103.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676578911","title":"股市必读:苑东生物新发布《苑东生物:关于自愿披露泊那替尼片获得药品注册证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2676578911","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676578911?lang=zh_cn&edition=full","pubTime":"2026-10-19 01:32","pubTimestamp":1792344730,"startTime":"0","endTime":"0","summary":"截至2026年10月16日收盘,苑东生物报收于45.39元,下跌1.33%,换手率1.14%,成交量2.01万手,成交额9500.49万元。公司公告汇总:苑东生物全资子公司获批泊那替尼片《药品注册证书》,为国内首家按化学药品4类获批的仿制药,视同通过一致性评价。公司公告汇总苑东生物:关于自愿披露泊那替尼片获得药品注册证书的公告成都苑东生物制药股份有限公司全资子公司成都硕德药业有限公司近日收到国家药品监督管理局核准签发的泊那替尼片《药品注册证书》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900000472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674845624","title":"股市必读:苑东生物新发布《苑东生物:关于自愿披露维生素K?注射液获得药品注册证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674845624","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674845624?lang=zh_cn&edition=full","pubTime":"2026-10-12 02:10","pubTimestamp":1791742225,"startTime":"0","endTime":"0","summary":"截至2026年10月9日收盘,苑东生物报收于46.19元,下跌2.76%,换手率1.47%,成交量2.6万手,成交额1.19亿元。当日关注点交易信息汇总:10月9日主力资金净流出954.3万元,占总成交额8.04%。公司公告汇总:苑东生物维生素K注射液获药品注册证书,注册分类为化学药品3类,视同通过仿制药一致性评价,公司为国内第三家获批该规格的企业。该规格用于预防和治疗婴儿维生素K缺乏性出血,公司为国内第三家获得该规格批件的企业。此前公司已获批1ml:10mg规格。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200000716.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688513","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673071562","title":"苑东生物最新公告:维生素K₁注射液获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2673071562","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673071562?lang=zh_cn&edition=full","pubTime":"2026-10-08 19:19","pubTimestamp":1791458397,"startTime":"0","endTime":"0","summary":"苑东生物(688513.SH)公告称,公司近日收到国家药监局核准签发的维生素K₁注射液《药品注册证书》,规格为0.2ml:2mg,注册分类为化学药品3类,视同通过仿制药一致性评价。该规格用于预防和治疗婴儿维生素K缺乏性出血,公司为国内第三家获批该规格仿制药的企业。米内网数据显示,维生素K₁注射液2026年半年度销售金额约4339万元。本次获批扩大了公司该药品的适应症范围,不会对近期业绩产生重大影响。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800028791.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688513","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673592027","title":"10月8日苑东生物跌7.15%,博时主题LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673592027","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673592027?lang=zh_cn&edition=full","pubTime":"2026-10-08 16:41","pubTimestamp":1791448882,"startTime":"0","endTime":"0","summary":"证券之星消息,10月8日苑东生物跌7.15%,收盘报47.5元,换手率1.35%,成交量2.38万手,成交额1.15亿元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共6家,其中持有数量最多的公募基金为博时基金的博时主题LOF。石炯在任的基金产品包括:博时研究优选混合A,管理时间为2023年9月1日至今,期间收益率为-0.56%;博时主题LOF的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800021341.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688513","160505","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671871241","title":"股市必读:苑东生物新发布《北京植德律师事务所关于成都苑东生物制药股份有限公司2026年第三次临时股东会的法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2671871241","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671871241?lang=zh_cn&edition=full","pubTime":"2026-09-30 01:52","pubTimestamp":1790704334,"startTime":"0","endTime":"0","summary":"公司公告汇总北京植德律师事务所关于成都苑东生物制药股份有限公司2026年第三次临时股东会的法律意见书北京植德律师事务所就成都苑东生物制药股份有限公司2026年第三次临时股东会的召集与召开程序、召集人资格、出席会议人员资格、表决程序及表决结果出具法律意见书。北京植德律师事务所对本次会议出具法律意见书,认为会议召集、召开程序及表决结果合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000002193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","BK0239","BK1574","01477","688513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670253190","title":"苑东生物(688513)披露2026年第三次临时股东会决议公告,9月28日股价下跌1.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670253190","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670253190?lang=zh_cn&edition=full","pubTime":"2026-09-28 22:12","pubTimestamp":1790604754,"startTime":"0","endTime":"0","summary":"截至2026年9月28日收盘,苑东生物报收于49.5元,较前一交易日下跌1.0%,最新总市值为87.38亿元。该股当日开盘50.11元,最高50.52元,最低49.0元,成交额达8249.37万元,换手率为0.94%。近日,苑东生物发布《2026年第三次临时股东会决议公告》。北京植德律师事务所对本次会议出具法律意见书,认为会议召集、召开程序及表决结果合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800034619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688513","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668232906","title":"每周股票复盘:机构调研关注苑东生物(688513)研发进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2668232906","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668232906?lang=zh_cn&edition=full","pubTime":"2026-09-20 01:26","pubTimestamp":1789838774,"startTime":"0","endTime":"0","summary":"截至2026年9月18日收盘,苑东生物(688513)报收于48.54元,较上周的44.65元上涨8.71%。本周,苑东生物9月18日盘中最高价报49.35元。9月14日盘中最低价报44.46元。苑东生物当前最新总市值85.69亿元,在化学制药板块市值排名58/149,在两市A股市值排名2093/5220。本周关注点来自机构调研要点:机构调研关注苑东生物研发进展机构调研要点机构调研关注苑东生物研发进展以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092000000255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688513","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667045196","title":"苑东生物最新公告:EP-0226片完成I期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2667045196","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667045196?lang=zh_cn&edition=full","pubTime":"2026-09-16 17:46","pubTimestamp":1789551971,"startTime":"0","endTime":"0","summary":"苑东生物(688513.SH)公告称,公司与中国科学院上海药物研究所等共同研发的1类化学创新药EP-0226片已完成用于治疗神经病理性疼痛的I期临床试验并取得统计分析结果。结果显示,该药物整体安全性、耐受性良好,口服吸收迅速,药物暴露量随剂量呈线性比例关系,多次给药后无明显蓄积,服用无需限制饮食。公司计划设置20mg、40mg、80mg三档剂量梯度开展II期临床研究。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600028352.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667659231","title":"9月14日苑东生物涨6.49%,博时主题LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667659231","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667659231?lang=zh_cn&edition=full","pubTime":"2026-09-14 16:37","pubTimestamp":1789375074,"startTime":"0","endTime":"0","summary":"证券之星消息,9月14日苑东生物涨6.49%,收盘报47.55元,换手率1.41%,成交量2.48万手,成交额1.17亿元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共6家,其中持有数量最多的公募基金为博时基金的博时主题LOF。石炯在任的基金产品包括:博时研究优选混合A,管理时间为2023年9月1日至今,期间收益率为-0.66%;博时主题LOF的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400021146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["160505","BK0239","688513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666578978","title":"苑东生物(688513)披露召开2026年第三次临时股东会的通知,9月11日股价下跌4.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666578978","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666578978?lang=zh_cn&edition=full","pubTime":"2026-09-11 22:37","pubTimestamp":1789137435,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘,苑东生物报收于44.65元,较前一交易日下跌4.04%,最新总市值为78.82亿元。近日,苑东生物发布《关于召开2026年第三次临时股东会的通知》。公告显示,公司将于2026年9月28日召开2026年第三次临时股东会,会议采取现场与网络投票相结合方式,网络投票通过上海证券交易所系统进行。股权登记日为2026年9月18日,A股股东均可参会。登记时间截至2026年9月24日,可通过现场或电子邮件、信函方式登记。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100050691.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665378020","title":"苑东生物:公司将于9月16日参加科创板2026年半年度创新药行业集体业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2665378020","media":"证券日报 ","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665378020?lang=zh_cn&edition=full","pubTime":"2026-09-08 20:16","pubTimestamp":1788869760,"startTime":"0","endTime":"0","summary":"9月8日,苑东生物发布公告称,公司将于9月16日参加科创板2026年半年度创新药行业集体业绩说明会。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-08/doc-inircrnn9176436.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-08/doc-inircrnn9176436.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159992","IBBQ","BK1161","BK1574","LNGR","BK0239","MEDX","KSTR","06978","688513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665332184","title":"苑东生物(688513)披露2026年第二次临时股东会决议公告,9月8日股价下跌1.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665332184","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665332184?lang=zh_cn&edition=full","pubTime":"2026-09-08 17:58","pubTimestamp":1788861491,"startTime":"0","endTime":"0","summary":"截至2026年9月8日收盘,苑东生物报收于45.39元,较前一交易日下跌1.63%,最新总市值为80.13亿元。该股当日开盘46.32元,最高46.5元,最低44.91元,成交额达8179.78万元,换手率为1.02%。公司于近日披露《2026年第二次临时股东会决议公告》,显示其于2026年9月7日召开2026年第二次临时股东会,审议通过《关于回购注销2024年员工持股计划部分股份的议案》和《关于终止部分募集资金投资项目并将剩余募集资金永久补充流动资金的议案》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800028298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688513","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665134383","title":"22家公司披露回购进展,ST绝味、苑东生物、佛燃能源回购金额居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2665134383","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665134383?lang=zh_cn&edition=full","pubTime":"2026-09-08 07:51","pubTimestamp":1788825060,"startTime":"0","endTime":"0","summary":"数据显示,9月8日,22家公司共发布22个股票回购相关进展。其中,4家公司首次披露股票回购预案,7家公司回购方案获股东大会通过,5家公司披露股票回购实施进展,6家公司回购方案已实施完毕。 ...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260908/c679676232.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260908/c679676232.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["002911","BK0238","688513","BK0252","BK0239","603517","BK0189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665362793","title":"股市必读:苑东生物新发布《苑东生物:关于股份回购实施结果的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2665362793","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665362793?lang=zh_cn&edition=full","pubTime":"2026-09-07 01:15","pubTimestamp":1788714911,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,苑东生物报收于44.5元,下跌1.07%,换手率0.87%,成交量1.53万手,成交额6842.8万元。公司公告汇总:苑东生物完成股份回购,累计回购1,386,528股,占总股本0.7854%,成交总金额6,075.35万元,回购实施完毕并进入后续处置程序。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700000613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688513","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793484878954,"stockEarnings":[{"period":"1week","weight":-0.113},{"period":"1month","weight":-0.1976},{"period":"3month","weight":-0.0812},{"period":"6month","weight":-0.356},{"period":"1year","weight":-0.2227},{"period":"ytd","weight":-0.3264}],"compareEarnings":[{"period":"1week","weight":-0.0248},{"period":"1month","weight":-0.0633},{"period":"3month","weight":-0.0609},{"period":"6month","weight":-0.1248},{"period":"1year","weight":-0.0973},{"period":"ytd","weight":-0.0932}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"成都苑东生物制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"5797人(较上一季度减少12.02%)","perCapita":"30452股","listingDate":"2020-09-02","address":"四川省成都市郫都区高新区西源大道8号","registeredCapital":"17653万元","survey":" 成都苑东生物制药股份有限公司的主营业务是化学原料药、高端化学药及生物药研发、生产和销售。公司的主要产品是化学制剂、化学原料药、CMO/CDMO、技术服务及转让。公司是国家高新技术企业,拥有“国家企业技术中心”、“博士后科研工作站”、“四川省固态药物工程技术研究中心”等多个创新平台,先后被认定为国家技术创新示范企业、国家企业技术中心、国家知识产权示范企业、国家绿色工厂,多次荣登中国化药企业百强、中国医药创新企业百强等榜单。","listedPrice":44.36},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"苑东生物(688513)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供苑东生物(688513)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"苑东生物,688513,苑东生物股票,苑东生物股票老虎,苑东生物股票老虎国际,苑东生物行情,苑东生物股票行情,苑东生物股价,苑东生物股市,苑东生物股票价格,苑东生物股票交易,苑东生物股票购买,苑东生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"苑东生物(688513)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供苑东生物(688513)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}